Bionano Genomics (BNGO) Stock: Why It's Up Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $1.26 as of 1:16 PM ET, +3.29% vs the prior close of $1.22.
- Volume 72.02K shares, 0.1x its 50-day average (light).
- New SEC filings: SCHEDULE 13G (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
Illumina (ILMN)Agilent Technologies (A)Waters (WAT)10x Genomics (TXG)Mettler Toledo International Inc/ (MTD)Revvity (RVTY)
BNGO jumps 3.3% to $1.26. Trading at $1.26 (intraday, 1:16 PM ET), +3.29% vs the prior close of $1.22. Day range $1.21–$1.28, opened at $1.21.
BNGO daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — BNGO jumps 3.3% to $1.26
- Trading at $1.26 (intraday, 1:16 PM ET), +3.29% vs the prior close of $1.22. Day range $1.21–$1.28, opened at $1.21.
- Volume was 72.02K shares, 0.1x its 50-day average of 1.16M — lighter than usual.
- Price is -8.4% vs its 50-day average ($1.38) and +0.1% vs its 200-day average ($1.26).
- 52-week range $1.00–$2.23; the current price sits at 21% of that range, 43.5% below the 52-week high.
Oct 19, 2026 — BNGO dips 2.4% to $1.22, a 1-month low, 3 down days in a row
- Closed at $1.22, -2.40% vs the prior close of $1.25. Day range $1.22–$1.27, opened at $1.27.
- Volume was 133.27K shares, 0.1x its 50-day average of 1.16M — lighter than usual.
- Price is -11.2% vs its 50-day average ($1.37) and -3.2% vs its 200-day average ($1.26).
- 52-week range $1.00–$2.23; today's close sits at 18% of that range, 45.3% below the 52-week high.
- That makes 3 straight losses.
Oct 16, 2026 — BNGO slides 8.8% to $1.25, a 1-month low
- Closed at $1.25, -8.76% vs the prior close of $1.37. Day range $1.25–$1.39, opened at $1.39.
- Volume was 180.75K shares, 0.2x its 50-day average of 1.16M — lighter than usual.
- Price is -8.9% vs its 50-day average ($1.37) and -0.9% vs its 200-day average ($1.26).
- 52-week range $1.00–$2.23; today's close sits at 20% of that range, 43.9% below the 52-week high.
Oct 15, 2026 — BNGO ends flat (+0.0%) to $1.37
- Closed at $1.37, +0.00% vs the prior close of $1.37. Day range $1.33–$1.40, opened at $1.38.
- Volume was 92.40K shares, 0.1x its 50-day average of 1.16M — lighter than usual.
- Price is +0.0% vs its 50-day average ($1.37) and +8.5% vs its 200-day average ($1.26).
- 52-week range $1.00–$2.23; today's close sits at 30% of that range, 38.6% below the 52-week high.
Oct 14, 2026 — BNGO rises 0.7% to $1.37
- Closed at $1.37, +0.74% vs the prior close of $1.36. Day range $1.36–$1.42, opened at $1.37.
- Volume was 157.70K shares, 0.1x its 50-day average of 1.16M — lighter than usual.
- Price is +0.5% vs its 50-day average ($1.36) and +8.4% vs its 200-day average ($1.26).
- 52-week range $1.00–$2.23; today's close sits at 30% of that range, 38.6% below the 52-week high.
Oct 13, 2026 — BNGO rises 0.7% to $1.36
- Closed at $1.36, +0.74% vs the prior close of $1.35. Day range $1.31–$1.40, opened at $1.34.
- Volume was 187.10K shares, 0.2x its 50-day average of 1.16M — lighter than usual.
- Price is +0.1% vs its 50-day average ($1.36) and +7.6% vs its 200-day average ($1.26).
- 52-week range $1.00–$2.23; today's close sits at 29% of that range, 39.0% below the 52-week high.
Oct 12, 2026 — BNGO slides 6.3% to $1.35, 3 down days in a row
- Closed at $1.35, -6.25% vs the prior close of $1.44. Day range $1.29–$1.42, opened at $1.41.
- Volume was 487.60K shares, 0.4x its 50-day average of 1.15M — lighter than usual.
- Price is -0.3% vs its 50-day average ($1.35) and +6.7% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 28% of that range, 39.5% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — BNGO dips 1.4% to $1.44
- Closed at $1.44, -1.37% vs the prior close of $1.46. Day range $1.43–$1.50, opened at $1.45.
- Volume was 129.40K shares, 0.1x its 50-day average of 1.16M — lighter than usual.
- Price is +6.8% vs its 50-day average ($1.35) and +13.7% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 36% of that range, 35.4% below the 52-week high.
Oct 8, 2026 — BNGO ends flat (+0.0%) to $1.46
- Closed at $1.46, +0.00% vs the prior close of $1.46. Day range $1.42–$1.49, opened at $1.46.
- Volume was 182.60K shares, 0.2x its 50-day average of 1.15M — lighter than usual.
- Price is +8.9% vs its 50-day average ($1.34) and +15.3% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 37% of that range, 34.5% below the 52-week high.
Oct 7, 2026 — BNGO rises 0.7% to $1.46
- Closed at $1.46, +0.69% vs the prior close of $1.45. Day range $1.42–$1.48, opened at $1.42.
- Volume was 132.00K shares, 0.1x its 50-day average of 1.15M — lighter than usual.
- Price is +9.5% vs its 50-day average ($1.33) and +15.2% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 37% of that range, 34.5% below the 52-week high.
Oct 6, 2026 — BNGO ends flat (+0.0%) to $1.45, 3 down days in a row
- Closed at $1.45, +0.00% vs the prior close of $1.45. Day range $1.43–$1.48, opened at $1.43.
- Volume was 202.20K shares, 0.2x its 50-day average of 1.15M — lighter than usual.
- Price is +9.4% vs its 50-day average ($1.33) and +14.3% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 37% of that range, 35.0% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — BNGO dips 2.0% to $1.45
- Closed at $1.45, -2.03% vs the prior close of $1.48. Day range $1.40–$1.50, opened at $1.48.
- Volume was 320.50K shares, 0.3x its 50-day average of 1.15M — lighter than usual.
- Price is +10.0% vs its 50-day average ($1.32) and +14.3% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 37% of that range, 35.0% below the 52-week high.
Oct 2, 2026 — BNGO slides 5.7% to $1.48
- Closed at $1.48, -5.73% vs the prior close of $1.57. Day range $1.45–$1.62, opened at $1.58.
- Volume was 383.40K shares, 0.3x its 50-day average of 1.14M — lighter than usual.
- Price is +12.8% vs its 50-day average ($1.31) and +16.6% vs its 200-day average ($1.27).
- 52-week range $1.00–$2.23; today's close sits at 39% of that range, 33.6% below the 52-week high.
BNGO bull case vs bear case (from the data)
- Price is +0.1% vs its 200-day average — above the long-term trend line.
- Insiders made 8 open-market purchases in the last 12 months.
- Price is -8.4% vs its 50-day average — short-term trend is down.
- Annual revenue fell 7.4% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $26.39M.
- Share count up 151.6% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BNGO latest news & SEC filings
Every SEC filing by or about BNGO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Luderer Albert bought 4,000 shares at $1.21 (≈$4.84K) on Sep 4, 2026
- Luderer Albert bought 4,000 shares at $1.21 (≈$4.84K) on Sep 4, 2026
- Luderer Albert bought 4,000 shares at $1.21 (≈$4.84K) on Sep 4, 2026
- Luderer Albert bought 4,000 shares at $1.21 (≈$4.84K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Luderer Albert bought 4,000 shares at $1.22 (≈$4.88K) on Aug 21, 2026
- Luderer Albert bought 4,000 shares at $1.22 (≈$4.88K) on Aug 21, 2026
- Luderer Albert bought 4,000 shares at $1.22 (≈$4.88K) on Aug 21, 2026
- Luderer Albert bought 4,000 shares at $1.22 (≈$4.88K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $8.17M (prior year $6.73M) (+21.4% vs Jun 30, 2025)
- Net income: -$7.42M (prior year -$6.86M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.64 (prior year -$1.99) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade BNGO
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 23, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.78% (largest 9.8%).
- Liquidity: about 334.51K shares (≈$421.51K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.26 vs a range of $1.00–$2.23 (21% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:60 on Jan 27, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Albert Luderer bought 4,000 shares on Sep 4, 2026.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Share count: 11.78M shares outstanding (Aug 6, 2026), +151.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Laboratory Analytical Instruments.
BNGO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.21 | 1.28 | 1.21 | 1.26 | 72.02K |
| Oct 19, 2026 | 1.27 | 1.29 | 1.22 | 1.22 | 133.30K |
| Oct 16, 2026 | 1.39 | 1.39 | 1.25 | 1.25 | 181.10K |
| Oct 15, 2026 | 1.38 | 1.40 | 1.33 | 1.37 | 92.40K |
| Oct 14, 2026 | 1.37 | 1.42 | 1.36 | 1.37 | 157.70K |
| Oct 13, 2026 | 1.34 | 1.40 | 1.31 | 1.36 | 187.10K |
| Oct 12, 2026 | 1.41 | 1.42 | 1.29 | 1.35 | 487.60K |
| Oct 9, 2026 | 1.45 | 1.50 | 1.43 | 1.44 | 129.40K |
| Oct 8, 2026 | 1.46 | 1.49 | 1.42 | 1.46 | 182.60K |
| Oct 7, 2026 | 1.42 | 1.48 | 1.42 | 1.46 | 132.00K |
| Oct 6, 2026 | 1.43 | 1.48 | 1.43 | 1.45 | 202.20K |
| Oct 5, 2026 | 1.48 | 1.50 | 1.40 | 1.45 | 320.50K |
| Oct 2, 2026 | 1.58 | 1.62 | 1.45 | 1.48 | 383.40K |
| Oct 1, 2026 | 1.58 | 1.60 | 1.54 | 1.57 | 373.90K |
| Sep 30, 2026 | 1.72 | 1.73 | 1.53 | 1.56 | 654.30K |
| Sep 29, 2026 | 1.68 | 1.77 | 1.65 | 1.73 | 422.30K |
| Sep 28, 2026 | 1.63 | 1.73 | 1.62 | 1.68 | 465.50K |
| Sep 25, 2026 | 1.69 | 1.70 | 1.63 | 1.66 | 578.70K |
| Sep 24, 2026 | 1.69 | 1.79 | 1.64 | 1.69 | 619.80K |
| Sep 23, 2026 | 1.81 | 1.83 | 1.68 | 1.70 | 914.30K |
About Bionano Genomics
Bionano Genomics (BNGO) is listed on the Nasdaq and classified by the SEC under “Laboratory Analytical Instruments”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1411690.
BNGO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David L Barker | Director | May 14, 2026 |
| R. Erik Holmlin | PRESIDENT AND CEO | Feb 18, 2026 |
| Yvonne Linney | Director | May 14, 2026 |
| Albert Luderer | Interim Chief Executive | Sep 9, 2026 |
| Aleksandar Rajkovic | Director | May 14, 2026 |
| Christopher J Twomey | Director | May 14, 2026 |
| Kristiina Md Vuori | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark Adamchak | Principal Accounting Officer | Aug 5, 2026 |
| Alka Chaubey | CHIEF MEDICAL OFFICER | Jun 3, 2026 |
| Jonathan V. Dixon | General Counsel | Aug 5, 2026 |
| Alex Reid Hastie | Chief Scientific Officer | Aug 5, 2026 |
| R. Erik Holmlin | PRESIDENT AND CEO | Feb 18, 2026 |
| Albert Luderer | Interim Chief Executive | Sep 9, 2026 |
| Mark Oldakowski | Chief Operating Officer | Aug 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 4, 2026 | Albert Luderer | Buy | 4,000 | $1.21 |
| Sep 4, 2026 | Albert Luderer | Buy | 4,000 | $1.21 |
| Sep 4, 2026 | Albert Luderer | Buy | 4,000 | $1.21 |
| Sep 4, 2026 | Albert Luderer | Buy | 4,000 | $1.21 |
| Aug 21, 2026 | Albert Luderer | Buy | 4,000 | $1.22 |
| Aug 21, 2026 | Albert Luderer | Buy | 4,000 | $1.22 |
| Aug 21, 2026 | Albert Luderer | Buy | 4,000 | $1.22 |
| Aug 21, 2026 | Albert Luderer | Buy | 4,000 | $1.22 |
BNGO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $28.51M | $-26.39M | -4.85 | $-16.34M |
| Dec 31, 2024 | $30.78M | $-112.02M | -88.13 | $-68.92M |
| Dec 31, 2023 | $36.12M | $-232.49M | -408.60 | $-125.18M |
| Dec 31, 2022 | $27.80M | $-132.60M | -4.58 | $-124.82M |
| Dec 31, 2021 | $17.98M | $-72.44M | -0.26 | $-71.93M |
Latest balance sheet: total assets $47.59M, total liabilities $15.98M, cash $3.73M (as of Jun 30, 2026).
BNGO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $1.16 |
| May 13, 2026 | 8-K Item 2.02 (results) | $1.25 |
| Mar 23, 2026 | 8-K Item 2.02 (results) | $1.46 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $1.59 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.47 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $3.21 |
| May 14, 2025 | 8-K Item 2.02 (results) | $3.74 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $2.79 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $13.20 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $16.80 |
| Oct 10, 2024 | 8-K Item 2.02 (results) | — |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Laboratory Analytical Instruments
Illumina (ILMN)Agilent Technologies (A)Waters (WAT)10x Genomics (TXG)Mettler Toledo International Inc/ (MTD)Revvity (RVTY)Avantor (AVTR)Bruker (BRKR)Bio-Rad Laboratories (BIO)Pacific Biosciences Of California (PACB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BNGO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.